Interview with Willlem Biantoro Wanandi , Chairman, Anugerah Corporation
The development of the Local Pharmaceutical industry companies has gone through rough times, competing from the…
Anugerah Corporation
Last updated: 13.02.2014
Address: jl. Senen Raya 135 Graha Atrium lt 16 jakarta 10410,Indonesia
Tel: + 62 021 3441330
Company description
Anugerah Corporation is a diversified holding company with its primary businesses in the pharmaceutical industry. Founded by Dr. Willem Wanandi in 1983 after he returned from chairing the WHO’s ‘Drug Action Plan’(DAP) in Geneva. The first business was PT Anugerah Pharmindo Lestari (APL) on the distribution side of the business. Combiphar, a generics manufacturer, was acquired in 1985. Tigaka Distrindo Perkasa (TDP) was then acquired in 1997 to expand the business into raw materials importing. Anugerah Corporation holds between 20-30 companies, including a number of smaller pharmaceutical service providers such as Pahala Bumi Pertiwi, Farmindo, Pharma Serve, Pharma Health Care, C2, Crush, SCH, BP, and AIL. Anugerah Corporation now holds a minority stake in APL, having sold 70% of the company to Zuellig in 2005. The group has 2500 employees across its various business, with Combiphar by far the largest at over 1000 employees. Combiphar has 15 OTC products and 122 Ethical drugs. They are seeking to incorporate nanotechnology as a key component of their new products, having launched Pronemia, a nano-iron supplement, in 2008.
Interviews
Related
Interview: Evie Yulin – Country Director, Merck Biopharma Indonesia
Evie Yulin, biopharma country director at Merck Indonesia, speaks towards the meaning of innovation in emerging…
Interview: Marlia Hayati Goestam – President Director & Joey Romana…
Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share…
Interview: Haris Izmee – Director, GE Healthcare Indonesia
Haris Izmee, director at GE Healthcare Indonesia, explains the strong commitment of the company towards improving…
Interview: Maura Linda Sitanggang – Director General, Ministry of Health,…
Maura Linda Sitanggang, director general at the Indonesian Ministry of Health, discusses the plans being rolled out…
The Indonesian Halal Law: A Headache for Pharma
The Halal Product Assurance Law, enacted in 2014 and due to be implemented across Indonesia in 2019, will mandate…
Interview: Milan Paleja – Country President & General Manager,…
Milan Paleja, country president and general manager of Novartis Indonesia, discusses his main priorities since…
Interview: Aylie Widjaja – Managing Director, Exeltis Indonesia
Aylie Widjaja, managing director at Exeltis Indonesia, shares her excitement about developing the company’s…
Interview: Patrick Kalona – Director, Phytochemindo Reksa, Indonesia
Patrick Kalona, Director at Phytochemindo Reksa draws a detailed picture of the traditional and herbal medicine…
Interview: Benoit Martineau – President Director, Sanofi Indonesia
Benoit Martineau, President Director at Sanofi Indonesia, explains the transformation of the Indonesian affiliate…
Interview: Saanjay Shamdasani – Head, Pharmaceutical and Life Sciences…
Saanjay Shamdasany, Director of Government Affairs & Public Policy at Baxter and Head of the Pharmaceutical and…
Interview: Suryo Suwignjo – President Director, Philips Indonesia
Suryo Suwignjo, President Director at Philips Indonesia, highlights the strong commitment and contribution of…
Interview: Darodjatun Sanusi – Executive Director, GP Farmasi, Indonesia
Darodjatun Sanusi, Executive Director of GP Farmasi (National Association of Local Companies in Indonesia),…
